MDxHealth SA (MDXH)
NASDAQ: MDXH · Real-Time Price · USD
1.705
+0.085 (5.26%)
Nov 21, 2024, 1:04 PM EST - Market open
MDxHealth Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for MDxHealth stock have an average target of 7.00, with a low estimate of 6.00 and a high estimate of 8.00. The average target predicts an increase of 310.56% from the current stock price of 1.71.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for MDxHealth stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 3 | 3 | 3 | 3 | 3 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $8 → $6 | Buy | Maintains | $8 → $6 | +251.91% | Nov 7, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $6 → $7 | Buy | Maintains | $6 → $7 | +310.56% | Mar 7, 2024 |
| BTIG | BTIG | Strong Buy Maintains $7 → $8 | Strong Buy | Maintains | $7 → $8 | +369.21% | Mar 7, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $10 → $6 | Buy | Maintains | $10 → $6 | +251.91% | Nov 9, 2023 |
| TD Cowen | TD Cowen | Buy Initiates $7 | Buy | Initiates | $7 | +310.56% | May 31, 2023 |
Financial Forecast
Revenue This Year
88.72M
from 70.19M
Increased by 26.39%
Revenue Next Year
105.29M
from 88.72M
Increased by 18.68%
EPS This Year
-1.22
from -1.66
EPS Next Year
-0.64
from -1.22
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 93.1M | 113.4M | 130.2M | |
| Avg | 88.7M | 105.3M | 120.1M | |
| Low | 83.3M | 93.1M | 102.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 32.7% | 27.8% | 23.7% | |
| Avg | 26.4% | 18.7% | 14.1% | |
| Low | 18.7% | 4.9% | -2.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | -1.07 | -0.53 | -0.26 | |
| Avg | -1.22 | -0.64 | -0.44 | |
| Low | -1.35 | -0.72 | -0.67 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | - | - | |
| Avg | - | - | - | |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.